CPT codes 55705, 55706 ( Biopsies, prostate, needle, transperineal, stereotactic template guided saturation sampling, including imaging guidance ), 55707 ( Biopsy, prostate, transrectal, ultrasound-guided (ie, sextant), ultrasound-localized ), 55708 ( Biopsy, prostate, transrectal, ultrasound-guided (ie, sextant) with MRI-fusion guidance ), 55709 ( Biopsy, prostate, transperineal, ultrasound-guided (ie, sextant), ultrasound-localized ), 55710 ( Biopsy, prostate, transperineal, ultrasound-guided (ie, sextant) with MRI-fusion guidance ), 55711 ( Biopsy, prostate, transrectal, MRI-ultrasound-fusion guided, targeted lesion(s) only ), 55712 ( Biopsy, prostate, transperineal, MRI-ultrasound-fusion guided, targeted lesion(s) only, first targeted lesion ), 55713 ( Biopsy, prostate, in-bore CT- or MRI-guided (ie, sextant), with biopsy of additional targeted lesion(s), first targeted lesion ), 55714 ( Biopsy, prostate, in-bore CT- or MRI-guided targeted lesion(s) only, first targeted lesion ), and 55715 ( Biopsy, prostate, each additional, MRI-ultrasound fusion or in-bore CT- or MRI-guided targeted lesion (List separately in addition to code for primary procedure) ), and 76872 were surveyed at the September 2024 RUC meeting
2023;doi:10.1016/S0140-6736(23)01163-7
Arbutin is one of my favourite skincare ingredients
143 A mitochondria-targeting nanoplatform was recently developed by conjugating folic acid-modified MCNs with the bioactive peptide M27-39, achieving dual therapeutic effects against both colorectal cancer and IBD
None of the three GLOW compounds are FDA-approved for injectable human use as of June 2026
